As an overworked joint, hips are prone to a range of orthopedic conditions, easily injured, and can rapidly deteriorate when left untreated. If you are experiencing orthopedic pain or instability, in or around your hip, groin, or upper leg area, please contact our patient care team to discuss if Regenexx Cayman stem cell therapy or platelet-rich plasma treatments are the right choice for you.
Regenexx-C can also be a non-surgical alternative for those who may be considering total hip replacement surgery (hip arthroplasty), labral repair, hip resurfacing, hip impingement surgery, or femoroacetabular impingement surgery.
If you’re experiencing severe hip pain, or wish to treat your hip alongside other joints, please contact us to tell us more about your condition and see if we can help you.
“After having such amazing results from my first treatment with Regenexx Cayman I decided to return to address the severe joint pain in my hips. The physicians are honest about what can be done and what can’t. I trust them completely.”
Regenexx tracks the post-procedure outcomes of every patient in an active registry. Here are some of the major findings from our Regenexx-C hip patient results:
2 years post-treatment, patients reported a functional level of 91%.
1 year post-treatment, patients reported that their pain levels decreased to an average of just 1.5 out of 10.
18 months post-treatment, patients report an overall improvement of 50%.
Regenexx Cayman blood platelet and stem cell treatments can help with a range of orthopedic hip problems, but a phone review will be required to confirm your candidacy for any of our treatments. During your phone review, the physician will thoroughly review your imaging, medical history, and treatment goals. You will then receive a candidacy rating of good, fair, or poor, so you have a clear understanding of your expected outcome from treatment.
While there can be early pain relief from our procedures, healing and regeneration of tissues takes time, and most patients notice a continuing decrease in pain and increase in function over many months post procedure.
The results from blood platelet treatments should become apparent over 6-12 weeks. The results from stem cell treatments should become apparent over 3-6 months. However, pain relief is variable, and it may take up to a year to achieve a stronger repair result.
Our Regenexx-C outcome data suggests that results peak at 1 - 2 years out. But this depends on numerous factors, including the condition of the area treated, a patient’s general health, etc.
Some patients find that one treatment delivers sufficient enough results for them, others may see mild to moderate results and wish to have additional treatments to further improve their outcome.
Yes, typically they do. Our outcome data shows that hip conditions are likely to respond better to the cultured stem cell treatment rather than same day stem cell treatment. Mild to moderate hip conditions often have great outcomes, and even severe hip conditions respond well to Regenexx-C treatment because of the higher concentration and cell yield.
While our hip patients have seen great results, not everyone is a candidate for treatment. A Regenexx Cayman physician will determine your candidacy before recommending treatment.
We track all our patient outcomes, and these are some of the results reported by our patients following Regenexx-C treatment:
2 years post-treatment, patients reported a functional level of 91%.
1 year post-treatment, patients reported that their pain levels decreased to an average of just 1.5 out of 10.
18 months post-treatment, patients report an overall improvement of 50%.
Yes. If your Regenexx Cayman physician recommends it, you can have both hips treated at the same time with blood platelet or stem cell treatments.
Regenexx is the trusted alternative to orthopedic surgery. We have treated many patients who have been told they need hip surgery or hip replacement. Many hip replacement patients report no significant improvements in their activity levels, however, according to our outcome data, 3 months following Regenexx-C hip treatment, patients reported an average functional level of 60%. Our goal is to improve function and reduce pain, helping you to avoid, or delay, surgery for as long as possible.
However, not everyone is a candidate for Regenexx-C, and sometimes surgery may still be your best option. During your Regenexx Cayman phone review you will receive a candidacy rating of good, fair, or poor, so you have a clear understanding of your options and potential outcomes.
We have treated many patients with arthritis who go on to report improved function and a reduction in pain after treatment. During your phone review, the physician will provide you with a candidacy score, so you understand your possible outcome.
Even if you have been told that your joint is “bone-on-bone”, this does not mean the joint should immediately be amputated. Our goal is help patients avoid the need for a more invasive surgery.
Our research has shown that small cartilage holes can heal with a precise, bone marrow-based stem cell procedure that delivers high doses of cells, but cartilage regeneration in severe arthritis remains unproven, and there is no evidence that it is possible to regrow cartilage in a “bone-on-bone” joint.
However, lack of cartilage is often not the cause of joint pain. Our patients have seen improved function and a reduction in pain after we’ve treated the surrounding joint structures. Even if you have been told that your joint is “bone-on-bone”, this does not mean the joint should immediately be amputated. Our goal is help patients avoid the need for a more invasive surgery.
We can provide joint-specific outcome data (i.e. all hip patients), but not condition-specific data. Regenexx maintains an active patient registry of all patients and publicly publishes the outcomes of those who have been treated by Regenexx-SD and blood platelet treatments. Regenexx Cayman also regularly compiles Regenexx-C data from the registry. Please contact us if you’d like to know more.
During your initial consultation, the physician will determine whether you will need crutches or a wheelchair. If required, Regenexx Cayman will provide you with crutches (to take home) or a wheelchair (for use on island).
This depends on your specific treatment, and you will be given specific post-procedure instructions to follow. However, most patients resume normal mobility and light resistance training 4 days after treatment and return to sport after 7 weeks. Patients also report a continued improvement in function and decrease in pain many months after their procedure.
Yes, we usually recommend physical therapy after treatment. You will receive specific post-procedure instructions and rehab protocols for your hip, including restricted and permitted activities, therapeutic exercises, rehab progression, and recommendations for physical therapy following stem cell injections.
